GeneDx Holdings Corp. (NASDAQ: WGS) Stock Competitors & Peer Comparison
See WGS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for WGS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WGS | $63.48 | +2.90% | 1.9B | 74.68 | $0.85 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
WGS vs VEEV Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas VEEV's P/E ratio is 23.46. In terms of profitability, WGS's ROE is -0.28%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, WGS is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for WGS.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
WGS vs GEHC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas GEHC's P/E ratio is 13.83. In terms of profitability, WGS's ROE is -0.28%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, WGS is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for WGS.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
WGS vs GEHCV Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas GEHCV's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, WGS is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for WGS.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
WGS vs BTSG Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas BTSG's P/E ratio is 57.01. In terms of profitability, WGS's ROE is -0.28%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for WGS.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
WGS vs BTSGU Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, WGS's ROE is -0.28%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for WGS.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
WGS vs TEM Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas TEM's P/E ratio is -104.94. In terms of profitability, WGS's ROE is -0.28%, compared to TEM's ROE of -0.70%. Regarding short-term risk, WGS is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for WGS.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
WGS vs SGFY Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SGFY's P/E ratio is 70.91. In terms of profitability, WGS's ROE is -0.28%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, WGS is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
WGS vs HQY Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HQY's P/E ratio is 23.06. In terms of profitability, WGS's ROE is -0.28%, compared to HQY's ROE of +0.11%. Regarding short-term risk, WGS is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
WGS vs HNGE Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HNGE's P/E ratio is 44.66. In terms of profitability, WGS's ROE is -0.28%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, WGS is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
WGS vs RCM Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas RCM's P/E ratio is -102.21. In terms of profitability, WGS's ROE is -0.28%, compared to RCM's ROE of +0.00%. Regarding short-term risk, WGS is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for WGS.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
WGS vs TXG Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas TXG's P/E ratio is -257.29. In terms of profitability, WGS's ROE is -0.28%, compared to TXG's ROE of -0.03%. Regarding short-term risk, WGS is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for WGS.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
WGS vs DOCS Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas DOCS's P/E ratio is 14.07. In terms of profitability, WGS's ROE is -0.28%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, WGS is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for WGS.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
WGS vs ONEM Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ONEM's P/E ratio is -7.77. In terms of profitability, WGS's ROE is -0.28%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, WGS is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
WGS vs PRVA Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas PRVA's P/E ratio is 168.13. In terms of profitability, WGS's ROE is -0.28%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, WGS is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for WGS.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
WGS vs PGNY Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas PGNY's P/E ratio is 23.31. In terms of profitability, WGS's ROE is -0.28%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, WGS is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for WGS.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
WGS vs HTFL Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HTFL's P/E ratio is -12.92. In terms of profitability, WGS's ROE is -0.28%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, WGS is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HTFL's competition here
Teladoc Health, Inc. (NYSE: TDOC)
WGS vs TDOC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas TDOC's P/E ratio is -10.47. In terms of profitability, WGS's ROE is -0.28%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, WGS is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for WGS.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
WGS vs NXGN Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas NXGN's P/E ratio is -266.00. In terms of profitability, WGS's ROE is -0.28%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, WGS is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for WGS.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
WGS vs OMDA Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas OMDA's P/E ratio is 338.57. In terms of profitability, WGS's ROE is -0.28%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, WGS is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for WGS.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
WGS vs AGTI Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas AGTI's P/E ratio is -71.79. In terms of profitability, WGS's ROE is -0.28%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, WGS is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for WGS.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
WGS vs GDRX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas GDRX's P/E ratio is 9.52. In terms of profitability, WGS's ROE is -0.28%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, WGS is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
WGS vs CERT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CERT's P/E ratio is 17.77. In terms of profitability, WGS's ROE is -0.28%, compared to CERT's ROE of -0.01%. Regarding short-term risk, WGS is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
WGS vs CCLDO Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CCLDO's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
WGS vs HSTM Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HSTM's P/E ratio is 38.08. In terms of profitability, WGS's ROE is -0.28%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, WGS is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
WGS vs WGSWW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, WGS's ROE is -0.28%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, WGS is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
WGS vs PHR Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, PHR has a market cap of 662M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas PHR's P/E ratio is 38.25. In terms of profitability, WGS's ROE is -0.28%, compared to PHR's ROE of +0.03%. Regarding short-term risk, WGS is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for WGS.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
WGS vs EVH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas EVH's P/E ratio is 580.00. In terms of profitability, WGS's ROE is -0.28%, compared to EVH's ROE of -0.78%. Regarding short-term risk, WGS is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for WGS.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
WGS vs MPLN-WT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, WGS is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
WGS vs ACCD Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ACCD's P/E ratio is -3.08. In terms of profitability, WGS's ROE is -0.28%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, WGS is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
WGS vs SHCR Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SHCR's P/E ratio is -3.76. In terms of profitability, WGS's ROE is -0.28%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, WGS is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
WGS vs CTEV Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CTEV's P/E ratio is -2.33. In terms of profitability, WGS's ROE is -0.28%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, WGS is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
WGS vs NRC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas NRC's P/E ratio is 26.56. In terms of profitability, WGS's ROE is -0.28%, compared to NRC's ROE of +0.57%. Regarding short-term risk, WGS is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for WGS.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
WGS vs SOPH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SOPH's P/E ratio is -11.29. In terms of profitability, WGS's ROE is -0.28%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, WGS is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for WGS.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
WGS vs SLGCW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, WGS's ROE is -0.28%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, WGS is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
WGS vs SLGC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SLGC's P/E ratio is -3.04. In terms of profitability, WGS's ROE is -0.28%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, WGS is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for WGS.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
WGS vs TBRG Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas TBRG's P/E ratio is 9.37. In terms of profitability, WGS's ROE is -0.28%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, WGS is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for WGS.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
WGS vs MPLN Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MPLN's P/E ratio is -0.23. In terms of profitability, WGS's ROE is -0.28%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, WGS is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
WGS vs SLP Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SLP's P/E ratio is 20.72. In terms of profitability, WGS's ROE is -0.28%, compared to SLP's ROE of +0.06%. Regarding short-term risk, WGS is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
WGS vs TRHC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas TRHC's P/E ratio is -4.27. In terms of profitability, WGS's ROE is -0.28%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, WGS is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for WGS.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
WGS vs SMFR Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SMFR's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, WGS is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for WGS.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
WGS vs SPOK Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SPOK's P/E ratio is 17.73. In terms of profitability, WGS's ROE is -0.28%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, WGS is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
WGS vs SY Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SY's P/E ratio is -5.09. In terms of profitability, WGS's ROE is -0.28%, compared to SY's ROE of -0.16%. Regarding short-term risk, WGS is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SY's competition here
American Well Corporation (NYSE: AMWL)
WGS vs AMWL Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas AMWL's P/E ratio is -2.54. In terms of profitability, WGS's ROE is -0.28%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, WGS is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for WGS.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
WGS vs HCAT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HCAT's P/E ratio is 11.25. In terms of profitability, WGS's ROE is -0.28%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, WGS is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
WGS vs CPSI Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CPSI's P/E ratio is -183.80. In terms of profitability, WGS's ROE is -0.28%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, WGS is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for WGS.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
WGS vs OPRX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas OPRX's P/E ratio is 6.14. In terms of profitability, WGS's ROE is -0.28%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, WGS is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
WGS vs AUGX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas AUGX's P/E ratio is -4.99. In terms of profitability, WGS's ROE is -0.28%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, WGS is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
WGS vs CCLD Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CCLD's P/E ratio is 8.59. In terms of profitability, WGS's ROE is -0.28%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
WGS vs DH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas DH's P/E ratio is 2.92. In terms of profitability, WGS's ROE is -0.28%, compared to DH's ROE of -0.67%. Regarding short-term risk, WGS is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for WGS.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
WGS vs FORA Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas FORA's P/E ratio is -24.11. In terms of profitability, WGS's ROE is -0.28%, compared to FORA's ROE of -0.17%. Regarding short-term risk, WGS is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for WGS.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
WGS vs CCLDP Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CCLDP's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
WGS vs ONMD Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ONMD's P/E ratio is -4.53. In terms of profitability, WGS's ROE is -0.28%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, WGS is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
WGS vs SNCE Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SNCE's P/E ratio is -0.27. In terms of profitability, WGS's ROE is -0.28%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, WGS is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
WGS vs AKLI Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas AKLI's P/E ratio is -0.71. In terms of profitability, WGS's ROE is -0.28%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, WGS is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for WGS.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
WGS vs SHLT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SHLT's P/E ratio is -3.87. In terms of profitability, WGS's ROE is -0.28%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, WGS is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
WGS vs SHCRW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, WGS's ROE is -0.28%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, WGS is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
WGS vs ONMDW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ONMDW's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, WGS is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
WGS vs STRM Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas STRM's P/E ratio is -2.40. In terms of profitability, WGS's ROE is -0.28%, compared to STRM's ROE of -0.32%. Regarding short-term risk, WGS is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for WGS.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
WGS vs RNLX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas RNLX's P/E ratio is -0.33. In terms of profitability, WGS's ROE is -0.28%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, WGS is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for WGS.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
WGS vs LIFW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas LIFW's P/E ratio is -0.02. In terms of profitability, WGS's ROE is -0.28%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, WGS is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
WGS vs EUDA Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas EUDA's P/E ratio is -21.32. In terms of profitability, WGS's ROE is -0.28%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, WGS is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for WGS.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
WGS vs BBLN Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas BBLN's P/E ratio is -0.04. In terms of profitability, WGS's ROE is -0.28%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, WGS is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for WGS.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
WGS vs BEATW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas BEATW's P/E ratio is -0.04. In terms of profitability, WGS's ROE is -0.28%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, WGS is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
WGS vs ETAO Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ETAO's P/E ratio is -0.01. In terms of profitability, WGS's ROE is -0.28%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, WGS is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for WGS.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
WGS vs BFRG Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas BFRG's P/E ratio is -1.20. In terms of profitability, WGS's ROE is -0.28%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, WGS is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for WGS.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
WGS vs HLTH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HLTH's P/E ratio is -0.02. In terms of profitability, WGS's ROE is -0.28%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, WGS is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for WGS.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
WGS vs SCNX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas SCNX's P/E ratio is -0.16. In terms of profitability, WGS's ROE is -0.28%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, WGS is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
WGS vs UPH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas UPH's P/E ratio is -0.07. In terms of profitability, WGS's ROE is -0.28%, compared to UPH's ROE of -1.05%. Regarding short-term risk, WGS is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for WGS.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
WGS vs UPH-WT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, WGS is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for WGS.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
WGS vs MGRX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MGRX's P/E ratio is -0.31. In terms of profitability, WGS's ROE is -0.28%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, WGS is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
WGS vs PEAR Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas PEAR's P/E ratio is -0.08. In terms of profitability, WGS's ROE is -0.28%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, WGS is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for WGS.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
WGS vs PEARW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas PEARW's P/E ratio is -0.00. In terms of profitability, WGS's ROE is -0.28%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, WGS is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
WGS vs OTRK Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas OTRK's P/E ratio is -0.02. In terms of profitability, WGS's ROE is -0.28%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, WGS is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for WGS.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
WGS vs VSEEW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, WGS's ROE is -0.28%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, WGS is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
WGS vs HCTI Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas HCTI's P/E ratio is -0.23. In terms of profitability, WGS's ROE is -0.28%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, WGS is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for WGS.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
WGS vs CMAX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CMAX's P/E ratio is -0.00. In terms of profitability, WGS's ROE is -0.28%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, WGS is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
WGS vs VSEE Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas VSEE's P/E ratio is -0.19. In terms of profitability, WGS's ROE is -0.28%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, WGS is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for WGS.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
WGS vs ACON Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ACON's P/E ratio is -0.24. In terms of profitability, WGS's ROE is -0.28%, compared to ACON's ROE of -0.54%. Regarding short-term risk, WGS is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
WGS vs LIFWZ Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, WGS is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for WGS.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
WGS vs EUDAW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, WGS's ROE is -0.28%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, WGS is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
WGS vs WORX Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas WORX's P/E ratio is -0.76. In terms of profitability, WGS's ROE is -0.28%, compared to WORX's ROE of -0.65%. Regarding short-term risk, WGS is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for WGS.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
WGS vs MSPRZ Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, WGS is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
WGS vs KERN Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas KERN's P/E ratio is -0.01. In terms of profitability, WGS's ROE is -0.28%, compared to KERN's ROE of -0.17%. Regarding short-term risk, WGS is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for WGS.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
WGS vs KERNW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas KERNW's P/E ratio is -0.00. In terms of profitability, WGS's ROE is -0.28%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, WGS is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for WGS.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
WGS vs LIFWW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas LIFWW's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, WGS is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
WGS vs ZCMD Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, WGS's ROE is -0.28%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, WGS is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for WGS.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
WGS vs CMAXW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CMAXW's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, WGS is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
WGS vs ACONW Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas ACONW's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, WGS is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for WGS.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
WGS vs MTBCO Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MTBCO's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for WGS.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
WGS vs MSPRV Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MSPRV's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MSPRV's ROE of N/A. Regarding short-term risk, WGS is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
WGS vs MTBCP Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MTBCP's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, WGS is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for WGS.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
WGS vs MTBC Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas MTBC's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, WGS is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for WGS.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
WGS vs CHNG Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CHNG's P/E ratio is -152.72. In terms of profitability, WGS's ROE is -0.28%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, WGS is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
WGS vs CHNGU Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CHNGU's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, WGS is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
WGS vs CNVY Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CNVY's P/E ratio is -71.50. In terms of profitability, WGS's ROE is -0.28%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, WGS is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
WGS vs NAVA Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas NAVA's P/E ratio is N/A. In terms of profitability, WGS's ROE is -0.28%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, WGS is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for WGS.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
WGS vs CERN Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CERN has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CERN's P/E ratio is 55.84. In terms of profitability, WGS's ROE is -0.28%, compared to CERN's ROE of +0.14%. Regarding short-term risk, WGS is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
WGS vs CSLT Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas CSLT's P/E ratio is -37.27. In terms of profitability, WGS's ROE is -0.28%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, WGS is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for WGS.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
WGS vs NH Comparison July 2026
GeneDx Holdings Corp. (NASDAQ: WGS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGS stands at 1.9B. In comparison, NH has a market cap of 0. Regarding current trading prices, WGS is priced at $63.48 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGS currently has a P/E ratio of 74.68, whereas NH's P/E ratio is -0.12. In terms of profitability, WGS's ROE is -0.28%, compared to NH's ROE of +0.35%. Regarding short-term risk, WGS is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for WGS.Check NH's competition here